Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars and Stephanie Grunewald ()
Additional contact information
Dwight Koeberl: Duke University School of Medicine
Andreas Schulze: Hospital for Sick Children and University of Toronto
Neal Sondheimer: Hospital for Sick Children and University of Toronto
Gerald S. Lipshutz: University of California at Los Angeles (UCLA)
Tarekegn Geberhiwot: University of Birmingham
Lerong Li: Inc.
Rajnish Saini: Inc.
Junxiang Luo: Inc.
Vanja Sikirica: Inc.
Ling Jin: Inc.
Min Liang: Inc.
Mary Leuchars: Inc.
Stephanie Grunewald: NIHR Biomedical Research Centre

Nature, 2024, vol. 629, issue 8011, E10-E10

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-024-07413-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:629:y:2024:i:8011:d:10.1038_s41586-024-07413-0

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-024-07413-0

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().